Open Access. Powered by Scholars. Published by Universities.®
- Institution
- Keyword
-
- Drugs (2)
- Food safety (2)
- Agreement on Trade-Related Aspects of Intellectual Property Rights (1994) (1)
- Allergy Prescription Drug Market (1)
- Ambiguity (1)
-
- Beef (1)
- Biotechnology (1)
- Bovine Spongiform Encephalopathy (1)
- Cattle (1)
- Clinical trials (1)
- Comprehensive Drug Abuse and Control Act (1)
- Creutzfeldt-Jakob Disease (1)
- DEA (1)
- Developing countries (1)
- Disclosure (1)
- Distribution Management Software (1)
- Drug Enforcement Administration (1)
- Drug approvals (1)
- Federal agencies (1)
- Food (1)
- Food Industry (1)
- Food Safety (1)
- Food and Drug Administration (1)
- Food and Drug Administration (“FDA”) (1)
- Food supply (1)
- Foodgate (1)
- Fort Laramie Treaty (1)
- GMO (1)
- Genetically modified foods (1)
- Hillary Clinton (1)
Articles 1 - 12 of 12
Full-Text Articles in Law
Public Perceptions Of Food Safety: Assessing The Risks Posed By Genetic Modification, Irradiation, Pesticides, Microbiological Contamination And High Fat/High Calorie Foods, Michael D. Mehta
The University of New Hampshire Law Review
[Excerpt] "In general, people in the developed world have access to a safe and varied supply of food. Instead of systemic hunger, many developed countries have problems with obesity and other kinds of eating disorders among their citizenry. It is within this context that some find public concerns about the safety of food both paradoxical and misplaced. Nevertheless, understanding how people perceive the risk associated with food is an important exercise in demonstrating accountability and in setting priorities for regulation. With the advent of technologies for producing genetically modified foods, and the development of fat blockers like Olestra, the public …
Importing Death As A Part Of Free Trade: An Argument For A Prohibition On The Importation Of Foods Containing The Residue Of Banned Pesticides, Derek Redmond
William & Mary Environmental Law and Policy Review
No abstract provided.
The Rx-To-Otc Switch Of Claritin, Allegra, And Zyrtec: An Unprecedented Fda Response To Petitioners And The Protection Of Public Health, Holly M. Spencer
The Rx-To-Otc Switch Of Claritin, Allegra, And Zyrtec: An Unprecedented Fda Response To Petitioners And The Protection Of Public Health, Holly M. Spencer
American University Law Review
No abstract provided.
Key Disclosure Issues For Life Sciences Companies: Fda Product Approval, Clinical Test Results, And Government Inspections, William O. Fisher
Key Disclosure Issues For Life Sciences Companies: Fda Product Approval, Clinical Test Results, And Government Inspections, William O. Fisher
Michigan Telecommunications & Technology Law Review
The government, particularly the Food and Drug Administration ("FDA"), heavily regulates the life sciences industry. FDA actions can have an extraordinary influence on the fortunes of biotechnology companies. Timely FDA approval of a drug or medical device can permit a company to exploit an inviting market window. FDA product approval is, in turn, tied to clinical test results which demonstrate "efficacy" and safety. Delayed approval, unfavorable test results, or the denial of an FDA application may ruin a company. Beyond the FDA product approval process and related testing lie FDA inspections and the possibility that the government will investigate charges …
Seeds Of Distrust: Federal Regulation Of Genetically Modified Foods, Thomas O. Mcgarity
Seeds Of Distrust: Federal Regulation Of Genetically Modified Foods, Thomas O. Mcgarity
University of Michigan Journal of Law Reform
This Article describes and evaluates the existing federal regulatory regime for protecting public health from risks posed by foods derived from GM plants. Part I briefly describes the technology involved in genetically modifying plants and relates the ongoing debates over the risks and benefits of GM food plants. Part II examines in detail the regulatory regime that has evolved in the United States to regulate the safety of GM foods, focusing in particular upon the pervasive role that the substantial equivalence doctrine has played in that regime. Finally, Part III suggests a more precautionary approach toward regulating GM foods that …
Law Meets Food: Breakfast At Hilary's, Fedwa Malti-Douglas
Law Meets Food: Breakfast At Hilary's, Fedwa Malti-Douglas
Indiana Law Journal
Symposium on "Law, Morality, and Popular Culture in the Public Sphere" at the Indiana University School of Law-Bloomington, April 6, 2001.
Bse: Risk, Uncertainty, And Policy Change, Enda Cummins, Pat Grace, Kevin Mcdonnell, Shane Ward
Bse: Risk, Uncertainty, And Policy Change, Enda Cummins, Pat Grace, Kevin Mcdonnell, Shane Ward
RISK: Health, Safety & Environment (1990-2002)
The authors discuss how, in our "risk society," a range of potential risks and uncertainties are associated with new technologies and new diseases, such as BSE. These risks bring with them worries about human health, while the ability to assess and manage new health scares is an essential skill for government and related industries.
When The Cure Is Worse Than The Disease: America's Failed War On Drugs, Peg Solomon
When The Cure Is Worse Than The Disease: America's Failed War On Drugs, Peg Solomon
Public Interest Law Reporter
No abstract provided.
Industrial Hemp: The Crop For The Seventh Generation, Robin Lash
Industrial Hemp: The Crop For The Seventh Generation, Robin Lash
American Indian Law Review
No abstract provided.
Dealing With International Aids: A Case Study In The Challenges Of Globalization, 35 J. Marshall L. Rev. 381 (2002), John G. Culhane
Dealing With International Aids: A Case Study In The Challenges Of Globalization, 35 J. Marshall L. Rev. 381 (2002), John G. Culhane
UIC Law Review
No abstract provided.
Reaping The Benefits Of Agricultural Biotechnology Through Uniform Regulation, 35 J. Marshall L. Rev. 433 (2002), Nathan W. Eckley
Reaping The Benefits Of Agricultural Biotechnology Through Uniform Regulation, 35 J. Marshall L. Rev. 433 (2002), Nathan W. Eckley
UIC Law Review
No abstract provided.
The Battle Over Life-Saving Pharmaceuticals: Are Developing Countries Being Tripped By Developed Countries, Michelle M. Nerozzi
The Battle Over Life-Saving Pharmaceuticals: Are Developing Countries Being Tripped By Developed Countries, Michelle M. Nerozzi
Villanova Law Review
No abstract provided.